Примери за използване на Products used in combination на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Please refer to the corresponding SmPC of medicinal products used in combination with ribavirin.
If other medicinal products used in combination with OLYSIO for the treatment of CHC are permanently discontinued for any reason, OLYSIO must also be discontinued.
Please refer to the corresponding SmPC of medicinal products used in combination with Ribavirin Teva.
In case of serious adverse reaction potentially related to medicinal products used in combination with Ribavirin Mylan, refer to the corresponding SmPC of these medicinal products as some combination regimens do not adhere to the ribavirin dose modification and/or discontinuation guidelines as described in Table 2.
For use in patients with decompensated cirrhosis, see the corresponding SmPC of the medicinal products used in combination with ribavirin.
Please refer to the corresponding SmPC of medicinal products used in combination with Rebetol for discontinuation or dose modification recommendations.
Dose adjustments of other medicinal products used in combination with cannabidiol A physician experienced in treating patients who are on concomitant antiepileptic drugs(AEDs) should evaluate the need for dose adjustments of cannabidiol or of the concomitant medicinal product(s) to manage potential drug interactions(see sections 4.4 and 4.5).
Please refer to the corresponding SmPC of medicinal products used in combination with Ribavirin Teva Pharma B.V.
In case of serious adverse reaction potentially related to medicinal products used in combination with Rebetol, refer to the corresponding SmPC of these medicinal products as some combination regimens do not adhere to the Rebetol dose modification and/or discontinuation guidelines as described in Table 2.
Refer to the Summary of Product Characteristics of the medicinal products used in combination with SIRTURO for their respective adverse reactions.
Please refer to the corresponding SmPC of medicinal products used in combination with Rebetol as some combination regimens do not adhere to the Rebetol dosing guidance provided in Table 1.
Dosage adjustment orinterruption of medicinal products used in combination with OLYSIO for the treatment of CHC.
Please refer to the corresponding SmPC of medicinal products used in combination with ribavirin as some combination regimens do not adhere to the ribavirin dosing guidance provided in Table 1.
Refer to the Summary of Product Characteristics of the medicinal products used in combination with SIRTURO for their respective adverse reactions.
Please refer to the corresponding Summary of Product Characteristics(SmPC)of medicinal products used in combination with Ribavirin Teva for prescribing information particular to that product and for further dosage recommendations on co-administration with Ribavirin Teva.
Refer to the respective Summary of Product Characteristics of the medicinal products used in combination with simeprevir regarding their use in patients with renal impairment.
Please refer to the corresponding Summary of Product Characteristics(SmPC)of medicinal products used in combination with Ribavirin Teva Pharma B.V. for prescribing information particular to that product and for further dosage recommendations on co-administration with Ribavirin Teva Pharma B.V.
The Summary of Product Characteristics for all medicinal products used in combination with Empliciti must be consulted before starting therapy.
Please refer to the corresponding SmPC of medicinal products used in combination with Rebetol for contraindications specific to these products. .
Please refer to the corresponding SmPC of medicinal products used in combination with Rebetol for further dosage recommendations on co-administration.
Refer to the respective Summary of Product Characteristics of the medicinal products used in combination with OLYSIO regarding their use in patients with renal impairment.
Refer to the respective Summary of Product Characteristics of the medicinal products used in combination with simeprevir regarding their use in patients with hepatic impairment.
For comprehensive dose adjustment recommendations and drug-associated adverse reactions for ritonavir andother medicinal products used in combination with saquinavir, physicians should refer to the Summary of Product Characteristics for each of these medicinal products. .
These products can be used in combination with heat, a special light, or a laser.
The HealthyPores package contains 3 different products that used in combination give skin the best opportunity to be healthy, shiny and fresh.
For the best results, these products should be used in combination with a balanced diet and exercise plan.
Please refer to the corresponding SmPC of medicinal products that are used in combination with ribavirin for additional undesirable effects reported with these products. .
Please refer to the corresponding SmPC of medicinal products that are used in combination with Rebetol for additional undesirable effects reported with these products. .